dHMN-2C

HSPB3 | 2010

What Is dHMN-2C?

dHMN-2C is a type of CMT caused by autosomal dominant mutations in the HSPB3 gene. This gene provides instructions for making a small heat-shock protein that supports the stability of nerve cells under stress. Mutations in the HSPB3 gene disrupt this function, leading to impaired nerve signal transmission.

dHMN-2C is autosomal dominant, meaning that just one of the gene’s two copies needs a mutation to cause this subtype.

Clinical Features

The age of symptom onset in dHMN-2C is variable, ranging from childhood to adulthood. Symptoms typically begin in the lower extremities and progress over time to involve the upper limbs. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

dHMN-2C symptoms may include:

  • Weakness in the feet and lower legs
  • Muscle atrophy
  • Foot drop
  • Reduced or absent reflexes
  • Reduced sensation
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands and forearms
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

dHMN-2C shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
dHMN-2C

Classification
dHMN/HMN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal dominant

Genetic Context

HGNC-Approved Gene Symbol
HSPB3

Gene Full Name
heat shock protein family B (small) member 3

HGNC Gene Alias(es)
HSPL27

Chromosome
5q11.2

Zygosity of Responsible Variant
Heterozygous

Variant Mechanism

Unknown

Details

Mechanistic basis:
Unresolved

Confidence:
Low

Prediction:
HSPB3 was tied to dHMN-2C by one dominant missense allele, R7S, in essentially a single family (Kolb et al. 2010). Small heat shock proteins act as oligomers and HSPB3 partners with HSPB2, so a mutant subunit could act on its partners rather than simply subtract activity, but the literature offers no HSPB3-specific functional study to distinguish reduced function from a toxic or interfering one.

Rationale:
Oligomeric chaperone biology makes an interfering effect the natural hypothesis, and the dominant alleles of the related HSPB1 and HSPB8 encourage it, yet no experiment has examined the R7S protein itself. A hypothesis borrowed from relatives of a gene is not evidence about that gene, which holds confidence low.

ClinVar Pathogenic Variants

View HSPB3 ClinVar Variants

dHMN-2C OMIM Entry

dHMN-2C OMIM

HSPB3 OMIM Entry

HSPB3 OMIM

More Info

dHMN-2C Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Mutant Small Heat Shock Protein B3 Causes Motor Neuropathy: Utility of a Candidate Gene Approach

Authors

Kolb, S. J., Snyder, P. J., Poi, E. J., Renard, E. A., Bartlett, A., Gu, S., Sutton, S., Arnold, W. D., Freimer, M. L., Lawson, V. H., Kissel, J. T., & Prior, T. W.

Publication Date
February 9, 2010

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.